title: Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone: report of two cases from South America.
authors.forename: Brady E
authors.initials: BE
authors.lastname: Beltran
authors.forename: Jorge J
authors.initials: JJ
authors.lastname: Castillo
authors.forename: Renzo
authors.initials: R
authors.lastname: Salas
authors.forename: Pilar
authors.initials: P
authors.lastname: Quiñones
authors.forename: Domingo
authors.initials: D
authors.lastname: Morales
authors.forename: Esther
authors.initials: E
authors.lastname: Cotrina
authors.forename: Roberto N
authors.initials: RN
authors.lastname: Miranda
authors.forename: Eduardo M
authors.initials: EM
authors.lastname: Sotomayor
mesh_terms: D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D020031:Epstein-Barr Virus Infections / Q000188:drug therapy* / Q000473:pathology / Q000821:virology; D004854:Herpesvirus 4, Human / Q000302:isolation & purification; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy* / Q000473:pathology / Q000821:virology; D008297:Male; D011239:Prednisolone / Q000008:administration & dosage; D011379:Prognosis; D000069283:Rituximab; D013020:South America; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone